Professor Timo Vesikari, MD, PhD, is the Founder and CEO of Nordic Research Network (NRN) Ltd. He has been Director of the Vaccine Research Center (VRC) at the University of Tampere from 2004 to 2019. His previous positions with the University include Professor of Pediatrics (1981–1987) and Professor of Virology (1991–2012). Timo Vesikari is a specialist in pediatric infectious diseases with a particular research interest in virology and viral vaccines. His research work has significantly contributed to the introduction of the rotavirus vaccine into childhood vaccination programs worldwide. Timo Vesikari has worked with the World Health Organization from 1988–1990 and has been a member of many WHO committees over the years. He has published over 350 peer-reviewed articles and co-edited a textbook on Pediatric Vaccines and Vaccinations (published 2017). VRC, under the leadership of Professor Vesikari, has conducted many pivotal vaccine trials leading to the licensure and implementation of several vaccines in addition to rotavirus vaccines. These include single and combined varicella vaccines, herpes zoster vaccines, live attenuated influenza vaccine, adjuvanted non-live influenza vaccine, pneumococcal conjugate vaccines, new hexavalent infant vaccines, and meningococcal vaccines. NRN, in association with the University of Tampere, has conducted three major clinical trials from 2007 to present. These studies have been on avian influenza vaccine, live herpes zoster vaccine, and, lastly, a new hepatitis B vaccine. All studies conducted by NRN have been in healthy adult volunteers ≥ 18 years of age. Professor Vesikari’s current research interest is the development of norovirus vaccines. He is a co-owner of a patent on a combined rotavirus VP6 and norovirus VLP vaccine.